Pictet Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Buy |
554,482
+10,569
| +2% | +$329K | 0.02% | 544 |
|
|
2025
Q1 | $17.6M | Buy |
543,913
+17,661
| +3% | +$570K | 0.02% | 528 |
|
|
2024
Q4 | $19M | Sell |
526,252
-34,343
| -6% | -$1.24M | 0.02% | 515 |
|
|
2024
Q3 | $17.2M | Buy |
560,595
+14,696
| +3% | +$452K | 0.02% | 531 |
|
|
2024
Q2 | $14.6M | Sell |
545,899
-444,137
| -45% | -$11.9M | 0.02% | 549 |
|
|
2024
Q1 | $33.6M | Sell |
990,036
-56,046
| -5% | -$1.9M | 0.04% | 380 |
|
|
2023
Q4 | $30.3M | Buy |
1,046,082
+125,530
| +14% | +$3.63M | 0.03% | 388 |
|
|
2023
Q3 | $25.4M | Buy |
+920,552
| New | +$25.4M | 0.03% | 404 |
|